Calyx Therapeutics is a US-based startup founded in 2019 that specializes in providing comprehensive and holistic physical therapy for pelvic and general orthopedic pain and dysfunction. Led by Cristina Shupe, PT, the company offers Integrative Physical Therapy for chronic pain and dysfunction, with a focus on Fascial Counterstrain, a specialized technique. Calyx Therapeutics operates within the Health Care and Health and Wellness industries, aiming to address a significant need for non-invasive and integrative therapies.
Although the exact details of the startup's last investment and the involved investors were not disclosed, Calyx Therapeutics presents a compelling opportunity within the healthcare sector, particularly given the rising demand for alternative pain management solutions. The company's dedication to providing insightful and comprehensive physical therapy positions it favorably within the market, with potential for growth and impact in addressing chronic pain and dysfunction.
There is no investment information
No recent news or press coverage available for Calyx Therapeutics.